Reports for XERESE
Brand name
XERESE
Company Name
BAUSCH HEALTH, CANADA INC.
|
Drug Identification Number
02404044 |
Ingredients
HYDROCORTISONE ACYCLOVIR |
Ingredient Strength
1 % 5 % |
ATC Code
D06BBD06BB D06BB |
ATC Descriptor
CHEMOTHERAPEUTICS FOR TOPICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE CHEMOTHERAPEUTICS FOR TOPICAL USE |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| XERESE | 5G | Resolved | 2017-03-17 | 2017-05-25 | 3303 |
| XERESE | n/a | Resolved | 2017-09-25 | 2018-02-13 | 23233 |
| XERESE | 5g | Resolved | 2018-04-12 | 2018-06-07 | 45574 |
| XERESE | n/a | Resolved | 2020-01-09 | 2020-03-05 | 102991 |
| XERESE | 5g | Avoided shortage | 2023-02-08 | 2023-04-11 | 183894 |
Showing 1 to 5 of 5
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0